{"ok": true, "database": "openregs", "query_name": "cross_reference", "rows": [["2026-09788", "Environmental Impact Statements; Notice of Availability", "Notice", "2026-05-15", "https://www.federalregister.gov/documents/2026/05/15/2026-09788/environmental-impact-statements-notice-of-availability", "EPA_FRDOC_0001-32815", "Environmental Impact Statements; Availability, etc.", "Notice", "EPA", "EPA_FRDOC_0001"], ["2026-09767", "Oscar Bobo: Final Debarment Order", "Notice", "2026-05-15", "https://www.federalregister.gov/documents/2026/05/15/2026-09767/oscar-bobo-final-debarment-order", "FDA-2025-N-0421-0002", "Oscar Bobo: Final Debarment Order", "Notice", "FDA", "FDA-2025-N-0421"], ["2026-09805", "Agency Information Collection Activities; Submission to the Office of Management and Budget; Federal Fish and Wildlife Permit Applications and Reports-Management Authority", "Notice", "2026-05-15", "https://www.federalregister.gov/documents/2026/05/15/2026-09805/agency-information-collection-activities-submission-to-the-office-of-management-and-budget-federal", "FWS-HQ-IA-2026-1915-0001", "Agency Information Collection Activities; Submission to the Office of Management and Budget; Federal Fish and Wildlife Permit Applications and Reports-Management Authority", "Notice", "FWS", "FWS-HQ-IA-2026-1915"], ["2026-09751", "Agency Information Collection Activities; Submission to the Office of Management and Budget; Horseshoe Crab and Cooperative Fish Tagging Programs", "Notice", "2026-05-15", "https://www.federalregister.gov/documents/2026/05/15/2026-09751/agency-information-collection-activities-submission-to-the-office-of-management-and-budget-horseshoe", "FWS-R5-FAC-2026-1684-0001", "Agency Information Collection Activities; Submission to the Office of Management and Budget; Horseshoe Crab and Cooperative Fish Tagging Programs", "Notice", "FWS", "FWS-R5-FAC-2026-1684"], ["2026-09807", "Foreign Endangered Species; Receipt of Permit Applications", "Notice", "2026-05-15", "https://www.federalregister.gov/documents/2026/05/15/2026-09807/foreign-endangered-species-receipt-of-permit-applications", "FWS-HQ-IA-2026-0298-0001", "Foreign Endangered Species; Receipt of Permit Applications", "Notice", "FWS", "FWS-HQ-IA-2026-0298"], ["2026-09833", "Request for Information on Modified Organisms Subject to the Plant Protection Act", "Proposed Rule", "2026-05-15", "https://www.federalregister.gov/documents/2026/05/15/2026-09833/request-for-information-on-modified-organisms-subject-to-the-plant-protection-act", "USDA_FRDOC_0001-3307", "Modified Organisms Subject to the Plant Protection Act", "Proposed Rule", "USDA", "USDA_FRDOC_0001"], ["2026-09695", "General Conference Committee of the National Poultry Improvement Plan; Solicitation for Membership", "Notice", "2026-05-14", "https://www.federalregister.gov/documents/2026/05/14/2026-09695/general-conference-committee-of-the-national-poultry-improvement-plan-solicitation-for-membership", "APHIS-2026-0101-0001", "Requests for Nominations: General Conference Committee of the National Poultry Improvement Plan", "Notice", "APHIS", "APHIS-2026-0101"], ["2026-09639", "Notice of Request for Revision To and Extension of Approval of an Information Collection; Restrictions on Importation of Live Poultry, Poultry Meat, and Other Poultry Products From Specified Regions", "Notice", "2026-05-14", "https://www.federalregister.gov/documents/2026/05/14/2026-09639/notice-of-request-for-revision-to-and-extension-of-approval-of-an-information-collection", "APHIS-2026-0496-0001", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Restrictions on Importation of Live Poultry, Poultry Meat, and Other Poultry Products from Specified Regions", "Notice", "APHIS", "APHIS-2026-0496"], ["2026-09618", "Air Plan Approval; Minnesota; Metropolitan Council Wastewater Treatment Plant Title I PM10 SIP Revisions", "Rule", "2026-05-14", "https://www.federalregister.gov/documents/2026/05/14/2026-09618/air-plan-approval-minnesota-metropolitan-council-wastewater-treatment-plant-title-i-pm10-sip", "EPA-R05-OAR-2024-0268-0014", "Final approval of the Minnesota MCES PM10 SIP revision", "Rule", "EPA", "EPA-R05-OAR-2024-0268"], ["2026-09613", "Air Plan Approval; Illinois; Moderate Attainment Plan Elements for the Chicago and Metro East Areas for the 2015 Ozone Standard", "Rule", "2026-05-14", "https://www.federalregister.gov/documents/2026/05/14/2026-09613/air-plan-approval-illinois-moderate-attainment-plan-elements-for-the-chicago-and-metro-east-areas", "EPA-R05-OAR-2024-0617-0005", "Final approval of the Illinois 2015 Ozone Moderate Attainment Plan Elements for Chicago and Metro-East St. Louis", "Rule", "EPA", "EPA-R05-OAR-2024-0617"], ["2026-09612", "Air Plan Approval; Indiana; Indiana NOX Emissions Monitoring", "Rule", "2026-05-14", "https://www.federalregister.gov/documents/2026/05/14/2026-09612/air-plan-approval-indiana-indiana-nox-emissions-monitoring", "EPA-R05-OAR-2021-0761-0006", "Final approval of Indiana NOx Emissions Monitoring", "Rule", "EPA", "EPA-R05-OAR-2021-0761"], ["2026-09588", "Clean Air Act Tribal Minor New Source Review Permit Issued to Jamul Casino Resort", "Notice", "2026-05-14", "https://www.federalregister.gov/documents/2026/05/14/2026-09588/clean-air-act-tribal-minor-new-source-review-permit-issued-to-jamul-casino-resort", "EPA-R09-OAR-2025-0454-0026", "Permits; Applications, Issuances, etc.: Jamul Casino Resort, Clean Air Act Tribal Minor New Source Review", "Notice", "EPA", "EPA-R09-OAR-2025-0454"], ["2026-09604", "Determination of Attainment by the Attainment Date and Clean Data Determination for the 2012 Annual Fine Particulate Standard; Plumas County, California", "Proposed Rule", "2026-05-14", "https://www.federalregister.gov/documents/2026/05/14/2026-09604/determination-of-attainment-by-the-attainment-date-and-clean-data-determination-for-the-2012-annual", "EPA-R09-OAR-2026-2608-0001", "Air Quality State Implementation Plans; Approvals and Promulgations: Determination of Attainment by the Attainment Date and Clean Data Determination for the 2012 Annual Fine Particulate Standard; Plumas County, CA", "Proposed Rule", "EPA", "EPA-R09-OAR-2026-2608"], ["2026-09613", "Air Plan Approval; Illinois; Moderate Attainment Plan Elements for the Chicago and Metro East Areas for the 2015 Ozone Standard", "Rule", "2026-05-14", "https://www.federalregister.gov/documents/2026/05/14/2026-09613/air-plan-approval-illinois-moderate-attainment-plan-elements-for-the-chicago-and-metro-east-areas", "EPA-R05-OAR-2024-0618-0006", "Final approval of the Illinois 2015 Ozone Moderate Attainment Plan Elements for Chicago and Metro-East St. Louis", "Rule", "EPA", "EPA-R05-OAR-2024-0618"], ["2026-09615", "Approval and Promulgation of Delegation of Authority for Designated Facilities and Pollutants; Washington; Northwest Clean Air Agency", "Rule", "2026-05-14", "https://www.federalregister.gov/documents/2026/05/14/2026-09615/approval-and-promulgation-of-delegation-of-authority-for-designated-facilities-and-pollutants", "EPA-R10-OAR-2026-0694-0001", "State Plans for Designated Facilities and Pollutants; Approvals and Promulgations: Washington; Northwest Clean Air Agency", "Rule", "EPA", "EPA-R10-OAR-2026-0694"], ["2026-09616", "Air Plan Approval; Michigan; Infrastructure SIP Requirements for the 2015 Ozone NAAQS; Michigan State Board Requirements", "Rule", "2026-05-14", "https://www.federalregister.gov/documents/2026/05/14/2026-09616/air-plan-approval-michigan-infrastructure-sip-requirements-for-the-2015-ozone-naaqs-michigan-state", "EPA-R05-OAR-2019-0215-0014", "Final approval of Michigan 2015 Ozone iSIP Element E State Board Requirements", "Rule", "EPA", "EPA-R05-OAR-2019-0215"], ["2026-09586", "Environmental Protection Agency Draft Fiscal Year 2027 Evidence Plan; Extension of Comment Period", "Notice", "2026-05-14", "https://www.federalregister.gov/documents/2026/05/14/2026-09586/environmental-protection-agency-draft-fiscal-year-2027-evidence-plan-extension-of-comment-period", "EPA_FRDOC_0001-32804", "Draft Fiscal Year 2027 Evidence Plan", "Notice", "EPA", "EPA_FRDOC_0001"], ["2026-09587", "Proposed CERCLA Cost Recovery Settlement for the Desha Road Superfund Site, Tappahannock, Essex County, Virginia", "Notice", "2026-05-14", "https://www.federalregister.gov/documents/2026/05/14/2026-09587/proposed-cercla-cost-recovery-settlement-for-the-desha-road-superfund-site-tappahannock-essex-county", "EPA_FRDOC_0001-32807", "Proposed Settlement Agreement, Stipulation, Order, and Judgment, etc.: CERCLA; Cost Recovery for the Desha Road Superfund Site, Tappahannock, Essex County, VA", "Notice", "EPA", "EPA_FRDOC_0001"], ["2026-09614", "Air Plan Approval; Ohio; Clean Data Determination for the Cleveland, Ohio Area for the 2015 Ozone Standard", "Rule", "2026-05-14", "https://www.federalregister.gov/documents/2026/05/14/2026-09614/air-plan-approval-ohio-clean-data-determination-for-the-cleveland-ohio-area-for-the-2015-ozone", "EPA-R05-OAR-2026-0562-0024", "Final approval of the Cleveland, Ohio 2015 Ozone Clean Data Determination", "Rule", "EPA", "EPA-R05-OAR-2026-0562"], ["2026-09619", "Air Plan Approval; Montana; Revisions to Western Sugar Stipulation", "Rule", "2026-05-14", "https://www.federalregister.gov/documents/2026/05/14/2026-09619/air-plan-approval-montana-revisions-to-western-sugar-stipulation", "EPA-R08-OAR-2025-2070-0009", "Air Quality State Implementation Plans; Approvals and Promulgations: Montana; Revisions to Western Sugar Stipulation", "Rule", "EPA", "EPA-R08-OAR-2025-2070"], ["2026-09603", "Alaska: Tentative Determination on Final Authorization of State Hazardous Waste Management Program", "Proposed Rule", "2026-05-14", "https://www.federalregister.gov/documents/2026/05/14/2026-09603/alaska-tentative-determination-on-final-authorization-of-state-hazardous-waste-management-program", "EPA-R10-RCRA-2026-2146-0009", "State Hazardous Waste Management Program: Alaska; Tentative Determination on Final Authorization", "Proposed Rule", "EPA", "EPA-R10-RCRA-2026-2146"], ["2026-09585", "2026 Annual Joint Meeting of the Ozone Transport Commission and the Mid-Atlantic Northeast Visibility Union", "Notice", "2026-05-14", "https://www.federalregister.gov/documents/2026/05/14/2026-09585/2026-annual-joint-meeting-of-the-ozone-transport-commission-and-the-mid-atlantic-northeast", "EPA_FRDOC_0001-32810", "Hearings, Meetings, Proceedings, etc.: Ozone Transport Commission and the Mid-Atlantic Northeast Visibility Union", "Notice", "EPA", "EPA_FRDOC_0001"], ["2026-09645", "Submission for OMB Review; Comment Request; Reinstatement", "Notice", "2026-05-14", "https://www.federalregister.gov/documents/2026/05/14/2026-09645/submission-for-omb-review-comment-request-reinstatement", "USDA_FRDOC_0001-3306", "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", "USDA", "USDA_FRDOC_0001"], ["2026-09519", "Notice of Request for Extension of Approval of an Information Collection; Federally Recognized State Managed Phytosanitary Program", "Notice", "2026-05-13", "https://www.federalregister.gov/documents/2026/05/13/2026-09519/notice-of-request-for-extension-of-approval-of-an-information-collection-federally-recognized-state", "APHIS-2026-0431-0001", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Federally Recognized State Managed Phytosanitary Program", "Notice", "APHIS", "APHIS-2026-0431"], ["2026-09490", "Oxirane, 2-phenyl-, polymer With oxirane, mono(hydrogen 2-sulfobutanedioate), octyl ether, sodium salt (1:2) in Pesticide Formulations; Exemption From the Requirement for a Tolerance", "Rule", "2026-05-13", "https://www.federalregister.gov/documents/2026/05/13/2026-09490/oxirane-2-phenyl--polymer-with-oxirane-monohydrogen-2-sulfobutanedioate-octyl-ether-sodium-salt-12", "EPA-HQ-OPP-2025-3360-0004", "Pesticide Tolerance; Exemptions, Petitions, Revocations, etc.: Oxirane, 2-phenyl-, polymer with oxirane, mono(hydrogen 2-sulfobutanedioate), octyl ether, sodium salt (1:2) in Pesticide Formulations", "Rule", "EPA", "EPA-HQ-OPP-2025-3360"], ["2026-09524", "Begin Actual Construction in the New Source Review (NSR) Preconstruction Permitting Program", "Proposed Rule", "2026-05-13", "https://www.federalregister.gov/documents/2026/05/13/2026-09524/begin-actual-construction-in-the-new-source-review-nsr-preconstruction-permitting-program", "EPA-HQ-OAR-2025-0618-0001", "Begin Actual Construction in the New Source Review Preconstruction Permitting Program", "Proposed Rule", "EPA", "EPA-HQ-OAR-2025-0618"], ["2026-09508", "Azodicarbonamide (ADA); Request for Information", "Notice", "2026-05-13", "https://www.federalregister.gov/documents/2026/05/13/2026-09508/azodicarbonamide-ada-request-for-information", "FDA-2026-N-4126-0001", "Azodicarbonamide (ADA); Request for Information", "Notice", "FDA", "FDA-2026-N-4126"], ["2026-09543", "Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting", "Notice", "2026-05-13", "https://www.federalregister.gov/documents/2026/05/13/2026-09543/agency-information-collection-activities-proposed-collection-comment-request-postmarketing-adverse", "FDA-2026-N-3098-0001", "Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting", "Notice", "FDA", "FDA-2026-N-3098"], ["2026-09507", "Butylated Hydroxytoluene (BHT); Request for Information", "Notice", "2026-05-13", "https://www.federalregister.gov/documents/2026/05/13/2026-09507/butylated-hydroxytoluene-bht-request-for-information", "FDA-2026-N-2526-0001", "Butylated Hydroxytoluene (BHT); Request for Information", "Notice", "FDA", "FDA-2026-N-2526"], ["2026-09544", "Modified Risk Tobacco Product Application: Renewal Applications for VLN\u00ae King and VLN\u00ae Menthol King, Cigarette Products Submitted by 22nd Century Group Inc.", "Notice", "2026-05-13", "https://www.federalregister.gov/documents/2026/05/13/2026-09544/modified-risk-tobacco-product-application-renewal-applications-for-vln-king-and-vln-menthol-king", "FDA-2019-N-0994-0230", "Modified Risk Tobacco Product Application: Renewal Applications for\nVLN\u00ae King and VLN\u00ae Menthol King, Cigarette Products Submitted by 22nd Century Group Inc.", "Notice", "FDA", "FDA-2019-N-0994"], ["2026-09448", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; The Real Cost Campaign Outcomes Evaluation Study: Cohort 3", "Notice", "2026-05-13", "https://www.federalregister.gov/documents/2026/05/13/2026-09448/agency-information-collection-activities-submission-for-office-of-management-and-budget-review", "FDA-2025-N-1600-0003", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; The Real Cost Campaign Outcomes Evaluation Study: Cohort 3", "Notice", "FDA", "FDA-2025-N-1600"], ["2026-09533", "Biomarker Incubator: Urinary Kidney Safety Biomarkers; Request for Information", "Notice", "2026-05-13", "https://www.federalregister.gov/documents/2026/05/13/2026-09533/biomarker-incubator-urinary-kidney-safety-biomarkers-request-for-information", "FDA-2026-N-0005-0001", "Biomarker Incubator: Urinary Kidney Safety Biomarkers; Request for Information", "Notice", "FDA", "FDA-2026-N-0005"], ["2026-09370", "Science Applications International Corporation; Access to Confidential Business Information", "Notice", "2026-05-12", "https://www.federalregister.gov/documents/2026/05/12/2026-09370/science-applications-international-corporation-access-to-confidential-business-information", "EPA-HQ-OPPT-2003-0004-0151", "Access to Confidential Business Information: Science Applications International Corp.", "Notice", "EPA", "EPA-HQ-OPPT-2003-0004"], ["2026-09366", "Drug Repurposing for Unmet Medical Needs; Request for Information", "Notice", "2026-05-12", "https://www.federalregister.gov/documents/2026/05/12/2026-09366/drug-repurposing-for-unmet-medical-needs-request-for-information", "FDA-2026-N-4492-0001", "Drug Repurposing for Unmet Medical Needs; Request for Information", "Notice", "FDA", "FDA-2026-N-4492"], ["2026-09438", "21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria web page", "Notice", "2026-05-12", "https://www.federalregister.gov/documents/2026/05/12/2026-09438/21st-century-cures-act-annual-compilation-of-notices-of-updates-from-the-susceptibility-test", "FDA-2017-N-5925-0040", "21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria web page", "Notice", "FDA", "FDA-2017-N-5925"], ["2026-09368", "Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization; Guidance for Industry; Availability", "Notice", "2026-05-12", "https://www.federalregister.gov/documents/2026/05/12/2026-09368/enforcement-priorities-for-certain-new-tobacco-products-marketed-without-premarket-authorization", "FDA-2026-D-5083-0001", "Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization; Guidance for Industry; Availability", "Notice", "FDA", "FDA-2026-D-5083"], ["2026-09335", "Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Microorganism Nucleic Acids and Resistance Markers From Patients With Suspected Orthopedic Infection", "Rule", "2026-05-12", "https://www.federalregister.gov/documents/2026/05/12/2026-09335/medical-devices-immunology-and-microbiology-devices-classification-of-the-device-to-detect-and", "FDA-2026-N-4274-0001", "Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Microorganism Nucleic Acids and Resistance Markers From Patients With Suspected Orthopedic Infection", "Rule", "FDA", "FDA-2026-N-4274"], ["2026-09244", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications On Medical Devices and Radiation-Emitting Products", "Notice", "2026-05-11", "https://www.federalregister.gov/documents/2026/05/11/2026-09244/agency-information-collection-activities-submission-for-office-of-management-and-budget-review", "FDA-2025-N-2220-0002", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications On Medical Devices and Radiation-Emitting Products", "Notice", "FDA", "FDA-2025-N-2220"], ["2026-09284", "Animal Generic Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Generic Drug User Fee Act Reauthorization; Request for Notification of Stakeholder Intent To Participate", "Notice", "2026-05-11", "https://www.federalregister.gov/documents/2026/05/11/2026-09284/animal-generic-drug-user-fee-act-stakeholder-consultation-meetings-on-the-animal-generic-drug-user", "FDA-2011-N-0655-0042", "Animal Generic Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Generic Drug User Fee Act Reauthorization; Request for\nNotification of Stakeholder Intent To Participate", "Notice", "FDA", "FDA-2011-N-0655"], ["2026-09242", "Issuance of Priority Review Voucher; Rare Pediatric Disease Product; AVLAYAH (tividenofusp alfa-eknm)", "Notice", "2026-05-11", "https://www.federalregister.gov/documents/2026/05/11/2026-09242/issuance-of-priority-review-voucher-rare-pediatric-disease-product-avlayah-tividenofusp-alfa-eknm", "FDA-2026-N-4573-0001", "Issuance of Priority Review Voucher; Rare Pediatric Disease Product; AVLAYAH (tividenofusp alfa-eknm)", "Notice", "FDA", "FDA-2026-N-4573"], ["2026-09269", "Pulmonary Tuberculosis: Developing Drugs for Treatment; Guidance for Industry; Availability", "Notice", "2026-05-11", "https://www.federalregister.gov/documents/2026/05/11/2026-09269/pulmonary-tuberculosis-developing-drugs-for-treatment-guidance-for-industry-availability", "FDA-2013-D-1319-0015", "Pulmonary Tuberculosis: Developing Drugs for Treatment; Guidance for Industry; Availability", "Notice", "FDA", "FDA-2013-D-1319"], ["2026-09268", "Postapproval Pregnancy Safety Studies; Guidance for Industry; Availability", "Notice", "2026-05-11", "https://www.federalregister.gov/documents/2026/05/11/2026-09268/postapproval-pregnancy-safety-studies-guidance-for-industry-availability", "FDA-2018-D-4693-0022", "Postapproval Pregnancy Safety Studies; Guidance for Industry; Availability", "Notice", "FDA", "FDA-2018-D-4693"], ["2026-09283", "Animal Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Drug User Fee Act Reauthorization; Request for Notification of Stakeholder Intent To Participate", "Notice", "2026-05-11", "https://www.federalregister.gov/documents/2026/05/11/2026-09283/animal-drug-user-fee-act-stakeholder-consultation-meetings-on-the-animal-drug-user-fee-act", "FDA-2011-N-0656-1315", "Animal Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Drug User Fee Act Reauthorization; Request for Notification of Stakeholder\nIntent To Participate", "Notice", "FDA", "FDA-2011-N-0656"], ["2026-09267", "Clostridioides Difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, or Prevention; Guidance for Industry; Availability", "Notice", "2026-05-11", "https://www.federalregister.gov/documents/2026/05/11/2026-09267/clostridioides-difficile-infection-developing-drugs-for-treatment-reduction-of-recurrence-or", "FDA-2022-D-1261-0003", "Clostridioides Difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, or Prevention; Guidance for Industry; Availability", "Notice", "FDA", "FDA-2022-D-1261"], ["2026-09233", "Foreign Endangered Species; Receipt of Permit Applications", "Notice", "2026-05-11", "https://www.federalregister.gov/documents/2026/05/11/2026-09233/foreign-endangered-species-receipt-of-permit-applications", "FWS-HQ-IA-2026-0760-0001", "Foreign Endangered Species; Receipt of Permit Applications", "Notice", "FWS", "FWS-HQ-IA-2026-0760"], ["2026-09234", "Foreign Endangered Species; Receipt of Permit Applications", "Notice", "2026-05-11", "https://www.federalregister.gov/documents/2026/05/11/2026-09234/foreign-endangered-species-receipt-of-permit-applications", "FWS-HQ-IA-2026-1057-0001", "Foreign Endangered Species; Receipt of Permit Applications", "Notice", "FWS", "FWS-HQ-IA-2026-1057"], ["2026-09180", "Environmental Impact Statements; Notice of Availability", "Notice", "2026-05-08", "https://www.federalregister.gov/documents/2026/05/08/2026-09180/environmental-impact-statements-notice-of-availability", "EPA_FRDOC_0001-32797", "Environmental Impact Statements; Availability, etc.", "Notice", "EPA", "EPA_FRDOC_0001"], ["2026-09146", "Air Plan Approval; NC; Removal of the State's Vehicle Inspection and Maintenance Program", "Proposed Rule", "2026-05-08", "https://www.federalregister.gov/documents/2026/05/08/2026-09146/air-plan-approval-nc-removal-of-the-states-vehicle-inspection-and-maintenance-program", "EPA-R04-OAR-2025-0305-0009", "Air Quality State Implementation Plans; Approvals and Promulgations: North Carolina; Removal of the State's Vehicle Inspection and Maintenance Program", "Proposed Rule", "EPA", "EPA-R04-OAR-2025-0305"], ["2026-09179", "Definition of Hazardous Waste Applicable to Corrective Action for Releases From Solid Waste Management Units; Withdrawal", "Proposed Rule", "2026-05-08", "https://www.federalregister.gov/documents/2026/05/08/2026-09179/definition-of-hazardous-waste-applicable-to-corrective-action-for-releases-from-solid-waste", "EPA-HQ-OLEM-2023-0085-0082", "Definition of Hazardous Waste Applicable to Corrective Action for Releases from Solid Waste Management Units; Withdrawal", "Proposed Rule", "EPA", "EPA-HQ-OLEM-2023-0085"], ["2026-09199", "Determination That Leucovorin Calcium, Oral Solution, Equivalent to 60 Milligrams Base/Vial, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "2026-05-08", "https://www.federalregister.gov/documents/2026/05/08/2026-09199/determination-that-leucovorin-calcium-oral-solution-equivalent-to-60-milligrams-basevial-was-not", "FDA-2026-P-0749-0004", "Determination That Leucovorin Calcium, Oral Solution, Equivalent to 60 Milligrams Base/Vial, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "FDA", "FDA-2026-P-0749"], ["2026-09152", "Medical Devices; Obstetrical and Gynecological Devices; Classification of the External Condom for Anal Intercourse or Vaginal Intercourse", "Rule", "2026-05-08", "https://www.federalregister.gov/documents/2026/05/08/2026-09152/medical-devices-obstetrical-and-gynecological-devices-classification-of-the-external-condom-for-anal", "FDA-2026-N-4659-0001", "Medical Devices; Obstetrical and Gynecological Devices; Classification of the External Condom for Anal Intercourse or Vaginal Intercourse", "Rule", "FDA", "FDA-2026-N-4659"], ["2026-09055", "Air Quality Plan; California; San Diego County Air Pollution Control District; Landfill Flares", "Proposed Rule", "2026-05-07", "https://www.federalregister.gov/documents/2026/05/07/2026-09055/air-quality-plan-california-san-diego-county-air-pollution-control-district-landfill-flares", "EPA-R09-OAR-2025-1641-0001", "Air Quality State Implementation Plans; Approvals and Promulgations: California; San Diego County Air Pollution Control District; Landfill Flares", "Proposed Rule", "EPA", "EPA-R09-OAR-2025-1641"], ["2026-09042", "Virginia; Waters of the Northern Neck Peninsula Vessel Sewage No-Discharge Zone; Final Affirmative Determination", "Notice", "2026-05-07", "https://www.federalregister.gov/documents/2026/05/07/2026-09042/virginia-waters-of-the-northern-neck-peninsula-vessel-sewage-no-discharge-zone-final-affirmative", "EPA-R03-OW-2025-2004-0006", "Final Affirmative Determination: Virginia; Waters of the Northern Neck Peninsula Vessel Sewage No-Discharge Zone", "Notice", "EPA", "EPA-R03-OW-2025-2004"], ["2026-09043", "Approval and Promulgation of Delegation of Authority for Designated Facilities and Pollutants; Allegheny County; Delegation of Authority of the Federal Plan for Existing Sewage Sludge Incineration Units", "Rule", "2026-05-07", "https://www.federalregister.gov/documents/2026/05/07/2026-09043/approval-and-promulgation-of-delegation-of-authority-for-designated-facilities-and-pollutants", "EPA-R03-OAR-2025-0487-0007", "State Plans for Designated Facilities and Pollutants; Approvals and Promulgations: Allegheny County; Delegation of Authority of the Federal Plan for Existing Sewage Sludge Incineration Units", "Rule", "EPA", "EPA-R03-OAR-2025-0487"], ["2026-09053", "Clean Air Act Operating Permit Program; Order on Petitions for Objection to State Operating Permits for Bargath, LLC's Clough, Heath, Hyrup, Jangles and Starkey Gulch Compressor Stations, and Grand River Gathering, LLC's East Mamm Creek Compressor Station", "Notice", "2026-05-07", "https://www.federalregister.gov/documents/2026/05/07/2026-09053/clean-air-act-operating-permit-program-order-on-petitions-for-objection-to-state-operating-permits", "EPA_FRDOC_0001-32793", "Clean Air Act Operating Permit Program: Order on Petitions for Objection to State Operating Permits for Bargath, LLC's Clough, Heath, Hyrup, Jangles and Starkey Gulch Compressor Stations, and Grand River Gathering, LLC's East Mamm Creek Compressor Station", "Notice", "EPA", "EPA_FRDOC_0001"], ["2026-09054", "Air Plan Approval; Missouri; Attainment Plan for the New Madrid Nonattainment Area for the 2010 1-Hour Sulfur Dioxide National Ambient Air Quality Standard", "Proposed Rule", "2026-05-07", "https://www.federalregister.gov/documents/2026/05/07/2026-09054/air-plan-approval-missouri-attainment-plan-for-the-new-madrid-nonattainment-area-for-the-2010-1-hour", "EPA-R07-OAR-2026-2938-0001", "Air Quality State Implementation Plans; Approvals and Promulgations: Missouri; Attainment Plan for the New Madrid Nonattainment Area for the 2010 1-hour Sulfur Dioxide National Ambient Air Quality Standard", "Proposed Rule", "EPA", "EPA-R07-OAR-2026-2938"], ["2026-09011", "Determination That MICARDIS (Telmisartan), Tablets, 20 Milligrams and 80 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "2026-05-07", "https://www.federalregister.gov/documents/2026/05/07/2026-09011/determination-that-micardis-telmisartan-tablets-20-milligrams-and-80-milligrams-were-not-withdrawn", "FDA-2025-P-7054-0006", "Determination That MICARDIS (Telmisartan), Tablets, 20 Milligrams and 80 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "FDA", "FDA-2025-P-7054"], ["2026-09023", "Patient-Matched Guides for Orthopedic Implants; Guidance for Industry and Food and Drug Administration Staff; Availability", "Notice", "2026-05-07", "https://www.federalregister.gov/documents/2026/05/07/2026-09023/patient-matched-guides-for-orthopedic-implants-guidance-for-industry-and-food-and-drug", "FDA-2023-D-2370-0007", "Patient-Matched Guides for Orthopedic Implants; Guidance for Industry and Food and Drug Administration Staff; Availability", "Notice", "FDA", "FDA-2023-D-2370"], ["2026-09012", "Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 15 Abbreviated New Drug Applications", "Notice", "2026-05-07", "https://www.federalregister.gov/documents/2026/05/07/2026-09012/teva-pharmaceuticals-usa-inc-et-al-withdrawal-of-approval-of-15-abbreviated-new-drug-applications", "FDA-2026-N-4291-0001", "Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 15 Abbreviated New Drug Applications", "Notice", "FDA", "FDA-2026-N-4291"], ["2026-09108", "Advisory Committee; Blood Products Advisory Committee; Renewal", "Notice", "2026-05-07", "https://www.federalregister.gov/documents/2026/05/07/2026-09108/advisory-committee-blood-products-advisory-committee-renewal", "FDA-2026-N-0008-0004", "Advisory Committee; Blood Products Advisory Committee; Renewal", "Notice", "FDA", "FDA-2026-N-0008"], ["2026-09093", "Receipt of Incidental Take Permit Application and Proposed Habitat Conservation Plan for Sand Skink and Blue-Tailed Mole Skink; Polk County, FL; Categorical Exclusion", "Notice", "2026-05-07", "https://www.federalregister.gov/documents/2026/05/07/2026-09093/receipt-of-incidental-take-permit-application-and-proposed-habitat-conservation-plan-for-sand-skink", "FWS-R4-ES-2026-0727-0001", "Receipt of Incidental Take Permit Application and Proposed Habitat Conservation Plan for Sand Skink and Blue-tailed Mole Skink; Polk County, FL; Categorical Exclusion (applicant: FLLWCC, LLC / FLOW CC, LLC)", "Notice", "FWS", "FWS-R4-ES-2026-0727"], ["2026-08808", "Pesticide Experimental Use Permit; Receipt of Application; Comment Request (December 2025)", "Notice", "2026-05-06", "https://www.federalregister.gov/documents/2026/05/06/2026-08808/pesticide-experimental-use-permit-receipt-of-application-comment-request-december-2025", "EPA-HQ-OPP-2025-3951-0001", "Permits; Applications, Issuances, etc.: Pesticide Experimental Use", "Notice", "EPA", "EPA-HQ-OPP-2025-3951"], ["2026-08913", "Issuance of Priority Review Voucher; Rare Pediatric Disease Product; OTARMENI (lunsotogene parvec-cwha)", "Notice", "2026-05-06", "https://www.federalregister.gov/documents/2026/05/06/2026-08913/issuance-of-priority-review-voucher-rare-pediatric-disease-product-otarmeni-lunsotogene-parvec-cwha", "FDA-2026-N-4588-0001", "Issuance of Priority Review Voucher; Rare Pediatric Disease Product; OTARMENI (lunsotogene parvec-cwha)", "Notice", "FDA", "FDA-2026-N-4588"], ["2026-08811", "Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Preserve and Stabilize Relative Abundances of Microbial Nucleic Acids in Clinical Samples", "Rule", "2026-05-06", "https://www.federalregister.gov/documents/2026/05/06/2026-08811/medical-devices-immunology-and-microbiology-devices-classification-of-the-device-to-preserve-and", "FDA-2026-N-4644-0001", "Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Preserve and Stabilize Relative Abundances of Microbial Nucleic Acids in Clinical Samples", "Rule", "FDA", "FDA-2026-N-4644"], ["2026-08939", "Determination That DEXAMETHASONE (Dexamethasone) Elixir, 0.5 Milligrams/5 Milliliters, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "2026-05-06", "https://www.federalregister.gov/documents/2026/05/06/2026-08939/determination-that-dexamethasone-dexamethasone-elixir-05-milligrams5-milliliters-was-not-withdrawn", "FDA-2026-P-1306-0004", "Determination That DEXAMETHASONE (Dexamethasone) Elixir, 0.5 Milligrams/5 Milliliters, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "FDA", "FDA-2026-P-1306"], ["2026-08812", "Medical Devices; Immunology and Microbiology Devices; Classification of the Circulating Tumor Cell Enrichment Device", "Rule", "2026-05-06", "https://www.federalregister.gov/documents/2026/05/06/2026-08812/medical-devices-immunology-and-microbiology-devices-classification-of-the-circulating-tumor-cell", "FDA-2026-N-4643-0001", "Medical Devices; Immunology and Microbiology Devices; Classification of the Circulating Tumor Cell Enrichment Device", "Rule", "FDA", "FDA-2026-N-4643"], ["2026-08813", "Medical Devices; Ophthalmic Devices; Classification of the Corneal Storage Medium With Preservatives Including Antifungals", "Rule", "2026-05-06", "https://www.federalregister.gov/documents/2026/05/06/2026-08813/medical-devices-ophthalmic-devices-classification-of-the-corneal-storage-medium-with-preservatives", "FDA-2026-N-4645-0001", "Medical Devices; Ophthalmic Devices; Classification of the Corneal Storage Medium With Preservatives Including Antifungals", "Rule", "FDA", "FDA-2026-N-4645"], ["2026-08969", "Endangered and Threatened Wildlife and Plants; Initiation of 5-Year Status Reviews for 78 Species in Hawaii, Idaho, Oregon, and California", "Notice", "2026-05-06", "https://www.federalregister.gov/documents/2026/05/06/2026-08969/endangered-and-threatened-wildlife-and-plants-initiation-of-5-year-status-reviews-for-78-species-in", "FWS-R1-ES-2026-0959-0001", "Endangered and Threatened Wildlife and Plants; Initiation of 5-Year Status Reviews for 78 Species in Hawaii, Idaho, Oregon, and California", "Notice", "FWS", "FWS-R1-ES-2026-0959"], ["2026-08682", "1,2-Dichloroethane; Final Risk Evaluation Under the Toxic Substances Control Act (TSCA); Notice of Availability", "Notice", "2026-05-05", "https://www.federalregister.gov/documents/2026/05/05/2026-08682/12-dichloroethane-final-risk-evaluation-under-the-toxic-substances-control-act-tsca-notice-of", "EPA-HQ-OPPT-2018-0427-0182", "1,2-Dichloroethane; Final Risk Evaluation Under the Toxic Substances Control Act (TSCA); Notice of Availability", "Notice", "EPA", "EPA-HQ-OPPT-2018-0427"], ["2026-08693", "Proposed Information Collection Request; Clean Water State Revolving Fund and Drinking Water State Revolving Fund Programs; EPA ICR No. 1803.10, OMB Control No. 2040-0185", "Notice", "2026-05-05", "https://www.federalregister.gov/documents/2026/05/05/2026-08693/proposed-information-collection-request-clean-water-state-revolving-fund-and-drinking-water-state", "EPA-HQ-OW-2002-0059-0029", "Proposed Information Collection Request; Clean Water State Revolving Fund and Drinking Water State Revolving Fund Programs; EPA ICR No. 1803.10, OMB Control No. 2040-0185", "Notice", "EPA", "EPA-HQ-OW-2002-0059"], ["2026-08750", "Extension of Postponement of Effectiveness for Certain Provisions of Trichloroethylene (TCE); Regulation Under the Toxic Substances Control Act (TSCA)", "Rule", "2026-05-05", "https://www.federalregister.gov/documents/2026/05/05/2026-08750/extension-of-postponement-of-effectiveness-for-certain-provisions-of-trichloroethylene-tce", "EPA-HQ-OPPT-2020-0642-0775", "Extension of Postponement of Effectiveness for Certain Provisions of Trichloroethylene (TCE); Regulation Under the Toxic Substances Control Act (TSCA)", "Rule", "EPA", "EPA-HQ-OPPT-2020-0642"], ["2026-08734", "Sport Fishing and Boating Partnership Council; Call for Nominations", "Notice", "2026-05-05", "https://www.federalregister.gov/documents/2026/05/05/2026-08734/sport-fishing-and-boating-partnership-council-call-for-nominations", "FWS-HQ-FAC-2026-1123-0001", "Sport Fishing and Boating Partnership Council; Call for Nominations", "Notice", "FWS", "FWS-HQ-FAC-2026-1123"], ["2026-08662", "Virginia: Approval of State Coal Combustion Residuals Permit Program", "Proposed Rule", "2026-05-04", "https://www.federalregister.gov/documents/2026/05/04/2026-08662/virginia-approval-of-state-coal-combustion-residuals-permit-program", "EPA-HQ-OLEM-2025-3325-0001", "Virginia: Approval of State Coal Combustion Residuals Permit Program", "Proposed Rule", "EPA", "EPA-HQ-OLEM-2025-3325"], ["2026-08604", "Agency Information Collection Activities; Proposed Collection; Comment Request; National Youth Tobacco Survey", "Notice", "2026-05-04", "https://www.federalregister.gov/documents/2026/05/04/2026-08604/agency-information-collection-activities-proposed-collection-comment-request-national-youth-tobacco", "FDA-2026-N-3070-0001", "Agency Information Collection Activities; Proposed Collection; Comment Request; National Youth Tobacco Survey", "Notice", "FDA", "FDA-2026-N-3070"], ["2026-08579", "Incidental Take Permit Application for the Desert Tortoise; Draft Habitat Conservation Plan and Draft Environmental Assessment; CalPortland-Oro Grande Quarries and Cement Plant, San Bernardino County, CA", "Notice", "2026-05-04", "https://www.federalregister.gov/documents/2026/05/04/2026-08579/incidental-take-permit-application-for-the-desert-tortoise-draft-habitat-conservation-plan-and-draft", "FWS-R8-ES-2025-0054-0001", "Incidental Take Permit Application for the Desert Tortoise; Draft Habitat Conservation Plan and Draft Environmental Assessment; CalPortland\u2014Oro Grande Quarries and Cement Plant, San Bernardino County, CA", "Notice", "FWS", "FWS-R8-ES-2025-0054"], ["2026-08574", "Endangered and Threatened Species; Receipt of Recovery Permit Applications", "Notice", "2026-05-04", "https://www.federalregister.gov/documents/2026/05/04/2026-08574/endangered-and-threatened-species-receipt-of-recovery-permit-applications", "FWS-R3-ES-2026-0860-0001", "Endangered and Threatened Species; Receipt of Recovery Permit Applications (applicant: Missouri Department of Conservation, Warsaw, MO)", "Notice", "FWS", "FWS-R3-ES-2026-0860"], ["2026-08592", "Endangered Species; Issuance of Permits", "Notice", "2026-05-04", "https://www.federalregister.gov/documents/2026/05/04/2026-08592/endangered-species-issuance-of-permits", "FWS-HQ-IA-2025-1441-0001", "Endangered Species; Issuance of Permits (applicant: Coastal Exotics, Inc.)", "Notice", "FWS", "FWS-HQ-IA-2025-1441"], ["2026-08665", "Endangered and Threatened Wildlife and Plants; 12-Month Not-Warranted Finding for the Temblor Legless Lizard", "Proposed Rule", "2026-05-04", "https://www.federalregister.gov/documents/2026/05/04/2026-08665/endangered-and-threatened-wildlife-and-plants-12-month-not-warranted-finding-for-the-temblor-legless", "FWS-R8-ES-2026-0299-0001", "Endangered and Threatened Species: 12-Month Not-Warranted Finding for the Temblor Legless Lizard", "Proposed Rule", "FWS", "FWS-R8-ES-2026-0299"], ["2026-08518", "National Emission Standards for Hazardous Air Pollutants: Ethylene Oxide Emissions Standards for Sterilization Facilities Residual Risk and Technology Review Reconsideration; Extension of Comment Period", "Proposed Rule", "2026-05-01", "https://www.federalregister.gov/documents/2026/05/01/2026-08518/national-emission-standards-for-hazardous-air-pollutants-ethylene-oxide-emissions-standards-for", "EPA-HQ-OAR-2019-0178-1675", "National Emission Standards for Hazardous Air Pollutants: Ethylene Oxide Emissions Standards for Sterilization Facilities Residual Risk and Technology Review Reconsideration; Extension of Comment Period", "Proposed Rule", "EPA", "EPA-HQ-OAR-2019-0178"], ["2026-08520", "Environmental Impact Statements; Notice of Availability", "Notice", "2026-05-01", "https://www.federalregister.gov/documents/2026/05/01/2026-08520/environmental-impact-statements-notice-of-availability", "EPA_FRDOC_0001-32784", "Environmental Impact Statements; Availability, etc.", "Notice", "EPA", "EPA_FRDOC_0001"], ["2026-08497", "Medical Devices; General and Plastic Surgery Devices; Classification of the Phototherapy Device for Reducing the Appearance of Acute Post-Surgical Incisions", "Rule", "2026-05-01", "https://www.federalregister.gov/documents/2026/05/01/2026-08497/medical-devices-general-and-plastic-surgery-devices-classification-of-the-phototherapy-device-for", "FDA-2026-N-4273-0001", "Medical Devices; General and Plastic Surgery Devices; Classification of the Phototherapy Device for Reducing the\nAppearance of Acute Post-Surgical Incisions", "Rule", "FDA", "FDA-2026-N-4273"], ["2026-08552", "List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act", "Notice", "2026-05-01", "https://www.federalregister.gov/documents/2026/05/01/2026-08552/list-of-bulk-drug-substances-for-which-there-is-a-clinical-need-under-section-503b-of-the-federal", "FDA-2018-N-3240-0377", "List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act", "Notice", "FDA", "FDA-2018-N-3240"], ["2026-08521", "Obesity and Drug Dosing: Clinical Pharmacology Considerations; Request for Comments", "Notice", "2026-05-01", "https://www.federalregister.gov/documents/2026/05/01/2026-08521/obesity-and-drug-dosing-clinical-pharmacology-considerations-request-for-comments", "FDA-2026-N-3499-0001", "Obesity and Drug Dosing: Clinical Pharmacology Considerations; Request for Comments", "Notice", "FDA", "FDA-2026-N-3499"], ["2026-08524", "Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comments", "Notice", "2026-05-01", "https://www.federalregister.gov/documents/2026/05/01/2026-08524/impacts-of-patient-focused-drug-development-meetings-establishment-of-a-public-docket-request-for", "FDA-2026-N-3947-0001", "Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comments", "Notice", "FDA", "FDA-2026-N-3947"], ["2026-08499", "Medical Devices; Exemptions From Premarket Notification: Certain Class II Devices; Request for Comments", "Notice", "2026-05-01", "https://www.federalregister.gov/documents/2026/05/01/2026-08499/medical-devices-exemptions-from-premarket-notification-certain-class-ii-devices-request-for-comments", "FDA-2026-N-4268-0001", "Medical Devices; Exemptions From Premarket Notification: Certain Class II Devices; Request for Comments", "Notice", "FDA", "FDA-2026-N-4268"], ["2026-08531", "Rescission of Final Determination: Adoption of Energy Efficiency Standards for New Construction of HUD- and USDA Financed Housing", "Notice", "2026-05-01", "https://www.federalregister.gov/documents/2026/05/01/2026-08531/rescission-of-final-determination-adoption-of-energy-efficiency-standards-for-new-construction-of", "USDA_FRDOC_0001-3302", "Rescission of Final Determination: Adoption of Energy Efficiency Standards for New Construction of Department of Housing and Urban Development and Department of Agriculture Financed Housing", "Notice", "USDA", "USDA_FRDOC_0001"], ["2026-08418", "Notice of Request for Revision to and Extension of Approval of an Information Collection; Pale Cyst Nematode", "Notice", "2026-04-30", "https://www.federalregister.gov/documents/2026/04/30/2026-08418/notice-of-request-for-revision-to-and-extension-of-approval-of-an-information-collection-pale-cyst", "APHIS-2026-0331-0001", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Pale Cyst Nematode", "Notice", "APHIS", "APHIS-2026-0331"], ["2026-08379", "Environmental Protection Agency Draft Fiscal Year 2027 Evidence Plan", "Notice", "2026-04-30", "https://www.federalregister.gov/documents/2026/04/30/2026-08379/environmental-protection-agency-draft-fiscal-year-2027-evidence-plan", "EPA_FRDOC_0001-32781", "Draft Fiscal Year 2027 Evidence Plan", "Notice", "EPA", "EPA_FRDOC_0001"], ["2026-08373", "Air Plan Approval; Delaware; Excess Emissions Provisions Pertaining to Periods of Startup, Shutdown and Malfunction Events", "Proposed Rule", "2026-04-30", "https://www.federalregister.gov/documents/2026/04/30/2026-08373/air-plan-approval-delaware-excess-emissions-provisions-pertaining-to-periods-of-startup-shutdown-and", "EPA-R03-OAR-2025-0215-0001", "Air Quality State Implementation Plans; Approvals and Promulgations: Delaware; Excess Emissions Provisions Pertaining to Periods of Startup, Shutdown and Malfunction Events", "Proposed Rule", "EPA", "EPA-R03-OAR-2025-0215"], ["2026-08372", "Utah; Northern Wasatch Front; 2015 8-Hour Ozone National Ambient Air Quality Standards; Reconsideration and Repeal of Finding of Failure To Attain and Reclassification to a Serious Nonattainment Area; Determination of Attainment by the Moderate Attainment Date But for International Emissions", "Proposed Rule", "2026-04-30", "https://www.federalregister.gov/documents/2026/04/30/2026-08372/utah-northern-wasatch-front-2015-8-hour-ozone-national-ambient-air-quality-standards-reconsideration", "EPA-R08-OAR-2024-0552-0004", "Air Quality State Implementation Plans; Approvals and Promulgations: Utah; Northern Wasatch Front; 2015 8-Hour Ozone National Ambient Air Quality Standards; Reconsideration and Repeal of Finding of Failure to Attain and Reclassification to a Serious Nonattainment Area; etc.", "Proposed Rule", "EPA", "EPA-R08-OAR-2024-0552"], ["2026-08370", "Comprehensive Environmental Response, Compensation, and Liability Act; Proposed Administrative Settlement Agreement for Recovery of Response Costs; Goodrich Asbestos Superfund Site in Ottawa County, Miami, Oklahoma", "Notice", "2026-04-30", "https://www.federalregister.gov/documents/2026/04/30/2026-08370/comprehensive-environmental-response-compensation-and-liability-act-proposed-administrative", "EPA_FRDOC_0001-32782", "Proposed Settlement Agreement, Stipulation, Order, and Judgment, etc.: CERCLA; Goodrich Asbestos Superfund Site in Ottawa County, Miami, OK", "Notice", "EPA", "EPA_FRDOC_0001"], ["2026-08425", "Medical Devices; Neurological Devices; Classification of the Brain Temperature Measurement System", "Rule", "2026-04-30", "https://www.federalregister.gov/documents/2026/04/30/2026-08425/medical-devices-neurological-devices-classification-of-the-brain-temperature-measurement-system", "FDA-2026-N-4269-0001", "Medical Devices; Neurological Devices; Classification of the Brain Temperature Measurement System", "Rule", "FDA", "FDA-2026-N-4269"], ["2026-08390", "Determination FENOGLIDE (Fenofibrate) Tablets, 40 Milligrams and 120 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "2026-04-30", "https://www.federalregister.gov/documents/2026/04/30/2026-08390/determination-fenoglide-fenofibrate-tablets-40-milligrams-and-120-milligrams-was-not-withdrawn-from", "FDA-2026-P-0655-0003", "Determination FENOGLIDE (Fenofibrate) Tablets, 40 Milligrams and 120 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "FDA", "FDA-2026-P-0655"], ["2026-08426", "Medical Devices; Cardiovascular Devices; Classification of the Laser-Powered Inferior Vena Cava Filter Retrieval Catheter", "Rule", "2026-04-30", "https://www.federalregister.gov/documents/2026/04/30/2026-08426/medical-devices-cardiovascular-devices-classification-of-the-laser-powered-inferior-vena-cava-filter", "FDA-2026-N-3946-0001", "Medical Devices; Cardiovascular Devices; Classification of the Laser-Powered Inferior Vena Cava Filter Retrieval Catheter", "Rule", "FDA", "FDA-2026-N-3946"], ["2026-08417", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Hazard Analysis and Critical Control Point Procedures for the Safe and Sanitary Processing and Importing of Juice", "Notice", "2026-04-30", "https://www.federalregister.gov/documents/2026/04/30/2026-08417/agency-information-collection-activities-submission-for-office-of-management-and-budget-review", "FDA-2026-N-0499-0002", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Hazard Analysis and Critical Control Point Procedures for the Safe and Sanitary Processing and Importing of Juice", "Notice", "FDA", "FDA-2026-N-0499"], ["2026-08378", "Advisory Committee; Pharmacy Compounding Advisory Committee; Renewal", "Notice", "2026-04-30", "https://www.federalregister.gov/documents/2026/04/30/2026-08378/advisory-committee-pharmacy-compounding-advisory-committee-renewal", "FDA-2026-N-0008-0003", "Advisory Committee; Pharmacy Compounding Advisory Committee; Renewal", "Notice", "FDA", "FDA-2026-N-0008"], ["2026-08435", "Determination That OZEMPIC (Semaglutide) Solution, 2 Milligrams Per 1.5 Milliliters Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "2026-04-30", "https://www.federalregister.gov/documents/2026/04/30/2026-08435/determination-that-ozempic-semaglutide-solution-2-milligrams-per-15-milliliters-was-not-withdrawn", "FDA-2025-P-3849-0004", "Determination That OZEMPIC (Semaglutide) Solution, 2 Milligrams Per 1.5 Milliliters Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "FDA", "FDA-2025-P-3849"], ["2026-08371", "Agency Information Collection Activities; Proposed Collection; Comment Request; Good Laboratory Practice Requirements for Nonclinical Laboratory Studies", "Notice", "2026-04-30", "https://www.federalregister.gov/documents/2026/04/30/2026-08371/agency-information-collection-activities-proposed-collection-comment-request-good-laboratory", "FDA-2026-N-3532-0001", "Agency Information Collection Activities; Proposed Collection; Comment Request; Good Laboratory Practice Requirements for Nonclinical Laboratory Studies", "Notice", "FDA", "FDA-2026-N-3532"], ["2026-08424", "Medical Devices; Radiology Devices; Classification of the Radiation Therapy Marking Device", "Rule", "2026-04-30", "https://www.federalregister.gov/documents/2026/04/30/2026-08424/medical-devices-radiology-devices-classification-of-the-radiation-therapy-marking-device", "FDA-2026-N-4270-0001", "Medical Devices; Radiology Devices; Classification of the Radiation Therapy Marking Device", "Rule", "FDA", "FDA-2026-N-4270"], ["2026-08455", "ChemoCentryx, Inc.; Proposal To Withdraw Approval of New Drug Application for TAVNEOS (Avacopan) Capsule, 10 Milligrams; Opportunity for a Hearing", "Notice", "2026-04-30", "https://www.federalregister.gov/documents/2026/04/30/2026-08455/chemocentryx-inc-proposal-to-withdraw-approval-of-new-drug-application-for-tavneos-avacopan-capsule", "FDA-2026-N-1321-0001", "ChemoCentryx, Inc.; Proposal To Withdraw Approval of New Drug Application for TAVNEOS (Avacopan) Capsule, 10 Milligrams; Opportunity for a Hearing", "Notice", "FDA", "FDA-2026-N-1321"]], "truncated": false, "columns": ["fr_document_number", "fr_title", "fr_type", "publication_date", "fr_url", "regs_document_id", "regs_title", "regs_type", "agency_id", "docket_id"], "query": {"sql": "SELECT xr.fr_document_number, fr.title AS fr_title, fr.type AS fr_type, fr.publication_date, fr.html_url AS fr_url, xr.regs_document_id, doc.title AS regs_title, doc.document_type AS regs_type, doc.agency_id, doc.docket_id FROM fr_regs_crossref xr LEFT JOIN federal_register fr ON fr.document_number = xr.fr_document_number LEFT JOIN documents doc ON doc.id = xr.regs_document_id WHERE (:fr_doc_number = '' OR xr.fr_document_number = :fr_doc_number) AND (:regs_doc_id = '' OR xr.regs_document_id = :regs_doc_id) ORDER BY fr.publication_date DESC LIMIT 100", "params": {"fr_doc_number": "", "regs_doc_id": ""}}, "error": null, "private": false, "allow_execute_sql": true, "query_ms": 1696.839557029307, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}